NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 4249339)

Published in Infect Immun on August 25, 2014

Authors

Holger Schäffler1, Dogan Doruk Demircioglu2, Daniel Kühner2, Sarah Menz3, Annika Bender3, Ingo B Autenrieth3, Peggy Bodammer4, Georg Lamprecht4, Friedrich Götz2, Julia-Stefanie Frick3

Author Affiliations

1: Division of Gastroenterology, Department of Medicine II, University of Rostock, Rostock, Germany holger.schaeffler@med.uni-rostock.de.
2: Microbial Genetics, University of Tübingen, Tübingen, Germany.
3: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany Deutsches Zentrum für Infektionsforschung (DZIF), Partner Side Tübingen, Tübingen, Germany.
4: Division of Gastroenterology, Department of Medicine II, University of Rostock, Rostock, Germany.

Articles cited by this

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 28.24

Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods (1999) 17.06

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science (2005) 11.31

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 10.79

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem (2003) 9.37

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science (2005) 8.97

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet (2001) 7.27

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol (2004) 5.59

Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol (1997) 5.21

Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A. J Biol Chem (1992) 4.92

Separation and quantification of muropeptides with high-performance liquid chromatography. Anal Biochem (1988) 4.65

Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol (2006) 4.55

Crohn's disease. Lancet (2012) 4.42

Dendritic cells in intestinal immune regulation. Nat Rev Immunol (2008) 4.20

Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest (2008) 2.88

Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide. Gut (2011) 2.80

Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol (2005) 2.76

Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut (2009) 2.75

Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep (2004) 2.64

Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe (2010) 2.49

Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol (2006) 2.40

Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology (2005) 2.25

TLR2 - promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology (2008) 2.19

Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog (2007) 1.92

NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol (2004) 1.90

Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol (2008) 1.78

Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun (2005) 1.76

The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity (2009) 1.68

Early response cytokines and innate immunity: essential roles for TNF receptor 1 and type I IL-1 receptor during Escherichia coli pneumonia in mice. J Immunol (2001) 1.45

Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol (2005) 1.41

The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun (2006) 1.41

Natural Staphylococcus aureus-derived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J (2010) 1.19

The molecular basis of NOD2 susceptibility mutations in Crohn's disease. Mucosal Immunol (2008) 1.19

Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol (2009) 1.18

Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One (2010) 1.14

Interleukin-12 and Th1 immune response in Crohn's disease: pathogenetic relevance and therapeutic implication. World J Gastroenterol (2006) 1.04

Role of mucosal dendritic cells in inflammatory bowel disease. World J Gastroenterol (2008) 1.04

Intestinal dendritic cells: their role in bacterial recognition, lymphocyte homing, and intestinal inflammation. Inflamm Bowel Dis (2010) 1.01

Cutting edge: primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J Immunol (2011) 0.89

A polymer-type water-soluble peptidoglycan exhibited both Toll-like receptor 2- and NOD2-agonistic activities, resulting in synergistic activation of human monocytic cells. Innate Immun (2008) 0.89

Nod2 downregulates TLR2/1 mediated IL1β gene expression in mouse peritoneal macrophages. PLoS One (2011) 0.79